Cargando…

Novel Tools, Biomarkers, and Disease Entities in Esophageal Disorders

Detalles Bibliográficos
Autores principales:	Yadlapati, Rena, Pandolfino, John E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Translational Medicine: Bench to Bedside
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817416/ https://www.ncbi.nlm.nih.gov/pubmed/26866393 http://dx.doi.org/10.1038/ctg.2016.7

Ejemplares similares

Endovascular interventions for central vein stenosis
por: Agarwal, Anil K.
Publicado: (2015)

Current progress in ABO-incompatible kidney transplantation
por: Koo, Tai Yeon, et al.
Publicado: (2015)

RNA sequencing of the nephron transcriptome: a technical note
por: Lee, Jae Wook
Publicado: (2015)

Organ-on-a-chip and the kidney
por: Kim, Sejoong, et al.
Publicado: (2015)

Use of Macrophage Inhibitory Cytokine-1 as a Biomarker in Screening and Surveillance of Colorectal Neoplasia
por: Bortniker, Ethan, et al.
Publicado: (2016)

Neuro-tracing approach to study kidney innervation: a technical note
por: Lee, Sanghee, et al.
Publicado: (2017)

Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021)

Lymphangiogenesis in Inflammatory Bowel Disease; A New Therapeutic Target?
por: Koutroubakis, Ioannis E, et al.
Publicado: (2016)

Coping Flexibility, GI Symptoms, and Functional GI Disorders: How Translational Behavioral Medicine Research Can Inform GI Practice
por: Radziwon, Christopher, et al.
Publicado: (2015)

Stem Cell Therapy for Inflammatory Bowel Disease
por: Lightner, Amy L
Publicado: (2017)

Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma
por: Sun, Dantong, et al.
Publicado: (2020)

Harnessing the Power of Posttranscriptional Gene Silencing in Crohn's Disease
por: Abdalla, Maisa, et al.
Publicado: (2016)

Recent Advances in Celiac Disease from TTG to Gluten in Pee
por: Silvester, J A, et al.
Publicado: (2015)

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
por: Lin, Chuan-Hao, et al.
Publicado: (2018)

Mechanisms Of Fructose Absorption
por: Noelting, Jessica, et al.
Publicado: (2015)

New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome
por: Barshop, Kenneth, et al.
Publicado: (2016)

Quelling Inflammation with Ketosis and Steric Chemistry
por: Gleeson, Michael W, et al.
Publicado: (2016)

Genetic Associations of Obesity: The Fat-Mass and Obesity-Associated (FTO) Gene
por: Ehrlich, Adam C, et al.
Publicado: (2016)

Muscle at Risk: The Multiple Impacts of Ammonia on Sarcopenia and Frailty in Cirrhosis
por: Chen, Hui-Wei, et al.
Publicado: (2016)

Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation
por: Cushing, Kelly, et al.
Publicado: (2015)

Capturing Islet Stem Cells for a Bio-Artificial Pancreas
por: Pothuloori, Avin P, et al.
Publicado: (2015)

Clinical Significance of Loss of ARID1A Expression in Colorectal and Small Intestinal Carcinoma
por: Putra, Juan, et al.
Publicado: (2015)

Clostridium difficile Infection
por: Feuerstadt, Paul
Publicado: (2015)

Genetics of the Serrated Pathway to Colorectal Cancer
por: Kedrin, Dmitriy, et al.
Publicado: (2015)

Bone Marrow-Derived Stem Cells in Pathogenesis of Helicobacter Pylori-Associated Gastric Cancer
por: Yaghoobi, Mohammad
Publicado: (2015)

Albumin Gains Immune Boosting Credibility
por: Gleeson, Michael W, et al.
Publicado: (2015)

The Role of Vitamin D and Vitamin D Receptors in Colon Cancer
por: Sun, Jun
Publicado: (2017)

Hormonal Management of Small Bowel Failure
por: Patel, Kumkum S, et al.
Publicado: (2017)

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy
por: Liu, Qiuli, et al.
Publicado: (2018)

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
por: Tsoli, Maria, et al.
Publicado: (2018)

A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib
por: Zhu, You-cai, et al.
Publicado: (2018)

Therapeutic approach guided by genetic alteration: Use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression
por: Lipkin, Jacob S, et al.
Publicado: (2015)

Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence
por: Abid, Muhammad Bilal, et al.
Publicado: (2016)

How breast cancer chemotherapy increases the risk of leukemia: Thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy
por: Zhang, Bin, et al.
Publicado: (2016)

Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report
por: Capalbo, Carlo, et al.
Publicado: (2014)

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?
por: Graziano, Vincenzo, et al.
Publicado: (2015)

Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy
por: Wyluda, Edward J, et al.
Publicado: (2015)

Metformin: a modulator of bevacizumab activity in cancer? A case report
por: Indraccolo, Stefano, et al.
Publicado: (2015)

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
por: Caggiari, Laura, et al.
Publicado: (2017)

Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing
por: Yang, Shanshan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3sl7m96e2bk1fuo9pa70rc8kdu